{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T09:07:35Z","timestamp":1792141655694,"version":"4.4.0"},"reference-count":259,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["pharmrev.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Reviews"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1124\/pharmrev.122.000590","type":"journal-article","created":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T16:40:49Z","timestamp":1664556049000},"page":"1176-1205","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Animal Behavior in Psychedelic Research"],"prefix":"10.1016","volume":"74","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6464-4831","authenticated-orcid":false,"given":"Anna U.","family":"Odland","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5613-1267","authenticated-orcid":false,"given":"Jesper L.","family":"Kristensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesper T.","family":"Andreasen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/pharmrev.122.000590_bib1","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1037\/0735-7044.99.5.881","article-title":"A proposed animal model for hallucinogens based on LSD\u2019s effects on patterns of exploration in rats","volume":"99","author":"Adams","year":"1985","journal-title":"Behav Neurosci"},{"key":"10.1124\/pharmrev.122.000590_bib2","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.neubiorev.2011.04.006","article-title":"Animal models of obsessive-compulsive disorder: exploring pharmacology and neural substrates","volume":"36","author":"Albelda","year":"2012","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1124\/pharmrev.122.000590_bib3","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2011.35","article-title":"Schizophrenia risk gene CAV1 is both pro-psychotic and required for atypical antipsychotic drug actions in vivo","volume":"1","author":"Allen","year":"2011","journal-title":"Transl Psychiatry"},{"key":"10.1124\/pharmrev.122.000590_bib4","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.2147\/NDT.S62785","article-title":"Animal models of obsessive-compulsive disorder: utility and limitations","volume":"11","author":"Alonso","year":"2015","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1124\/pharmrev.122.000590_bib5","doi-asserted-by":"crossref","first-page":"994","DOI":"10.3389\/fphar.2018.00994","article-title":"LSD administered as a single dose reduces alcohol consumption in C57BL\/6J mice","volume":"9","author":"Alper","year":"2018","journal-title":"Front Pharmacol"},{"key":"10.1124\/pharmrev.122.000590_bib6","doi-asserted-by":"crossref","first-page":"112861","DOI":"10.1016\/j.bbr.2020.112861","article-title":"Acute serotonin 2A receptor activation impairs behavioral flexibility in mice","volume":"395","author":"Amodeo","year":"2020","journal-title":"Behav Brain Res"},{"key":"10.1124\/pharmrev.122.000590_bib7","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0091-3057(99)00089-1","article-title":"Increasing the selectivity of drug discrimination procedures","volume":"64","author":"Appel","year":"1999","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/pharmrev.122.000590_bib8","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/01.fbp.0000189810.69425.89","article-title":"Effects of 5-HT2A receptor stimulation on the discrimination of durations by rats","volume":"17","author":"Asgari","year":"2006","journal-title":"Behav Pharmacol"},{"key":"10.1124\/pharmrev.122.000590_bib9","doi-asserted-by":"crossref","first-page":"eabl6989","DOI":"10.1126\/sciadv.abl6989","article-title":"Trips and neurotransmitters: discovering principled patterns across 6850 hallucinogenic experiences","volume":"8","author":"Ballentine","year":"2022","journal-title":"Sci Adv"},{"key":"10.1124\/pharmrev.122.000590_bib10","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1080\/15622975.2016.1181783","article-title":"Biological markers for anxiety disorders, OCD and PTSD - a consensus statement. Part I: Neuroimaging and genetics","volume":"17","author":"Bandelow","year":"2016","journal-title":"World J Biol Psychiatry"},{"key":"10.1124\/pharmrev.122.000590_bib11","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1080\/15622975.2016.1190867","article-title":"Biological markers for anxiety disorders, OCD and PTSD: a consensus statement. Part II: Neurochemistry, neurophysiology and neurocognition","volume":"18","author":"Bandelow","year":"2017","journal-title":"World J Biol Psychiatry"},{"key":"10.1124\/pharmrev.122.000590_bib12","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/7854_2017_474","article-title":"Classic hallucinogens and mystical experiences: phenomenology and neural correlates","volume":"36","author":"Barrett","year":"2018","journal-title":"Curr Top Behav Neurosci"},{"key":"10.1124\/pharmrev.122.000590_bib13","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1124\/mol.54.1.94","article-title":"Effector pathway-dependent relative efficacy at serotonin type 2A and 2C receptors: evidence for agonist-directed trafficking of receptor stimulus","volume":"54","author":"Berg","year":"1998","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pharmrev.122.000590_bib14","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/FBP.0000000000000628","article-title":"Effects of 5-HT2A receptor agonist 2,5-dimethoxy-4-iodoamphetamine on alcohol consumption in Long-Evans rats","volume":"32","author":"Berquist","year":"2021","journal-title":"Behav Pharmacol"},{"key":"10.1124\/pharmrev.122.000590_bib15","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.beproc.2005.10.004","article-title":"Evidence that the effect of 5-HT2 receptor stimulation on temporal differentiation is not mediated by receptors in the dorsal striatum","volume":"71","author":"Body","year":"2006","journal-title":"Behav Processes"},{"key":"10.1124\/pharmrev.122.000590_bib16","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/00008877-200312000-00004","article-title":"Effects of a 5-HT2 receptor agonist, DOI (2,5-dimethoxy-4-iodoamphetamine), and antagonist, ketanserin, on the performance of rats on a free-operant timing schedule","volume":"14","author":"Body","year":"2003","journal-title":"Behav Pharmacol"},{"key":"10.1124\/pharmrev.122.000590_bib17","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1177\/0269881114565144","article-title":"Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study","volume":"29","author":"Bogenschutz","year":"2015","journal-title":"J Psychopharmacol"},{"key":"10.1124\/pharmrev.122.000590_bib18","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/0006-3223(94)91176-2","article-title":"Sensorimotor gating and habituation evoked by electro-cutaneous stimulation in schizophrenia","volume":"36","author":"Bolino","year":"1994","journal-title":"Biol Psychiatry"},{"key":"10.1124\/pharmrev.122.000590_bib19","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1124\/mol.106.028720","article-title":"Molecular interaction of serotonin 5-HT2A receptor residues Phe339(6.51) and Phe340(6.52) with superpotent N-benzyl phenethylamine agonists","volume":"70","author":"Braden","year":"2006","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pharmrev.122.000590_bib20","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/j.1469-8986.1978.tb01390.x","article-title":"Prestimulus effects on human startle reflex in normals and schizophrenics","volume":"15","author":"Braff","year":"1978","journal-title":"Psychophysiology"},{"key":"10.1124\/pharmrev.122.000590_bib21","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/s002130100810","article-title":"Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies","volume":"156","author":"Braff","year":"2001","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/pharmrev.122.000590_bib22","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1177\/0269881120959637","article-title":"Pivotal mental states","volume":"35","author":"Brouwer","year":"2021","journal-title":"J Psychopharmacol"},{"key":"10.1124\/pharmrev.122.000590_bib23","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1007\/s40262-017-0540-6","article-title":"Pharmacokinetics of escalating doses of oral psilocybin in healthy adults","volume":"56","author":"Brown","year":"2017","journal-title":"Clin Pharmacokinet"},{"key":"10.1124\/pharmrev.122.000590_bib24","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3389\/fphar.2018.00017","article-title":"Tolerance and tachyphylaxis to head twitches induced by the 5-HT2A agonist 25CN-NBOH in mice","volume":"9","author":"Buchborn","year":"2018","journal-title":"Front Pharmacol"},{"key":"10.1124\/pharmrev.122.000590_bib25","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1177\/0269881114531666","article-title":"Repeated lysergic acid diethylamide in an animal model of depression: normalisation of learning behaviour and hippocampal serotonin 5-HT2 signalling","volume":"28","author":"Buchborn","year":"2014","journal-title":"J Psychopharmacol"},{"key":"10.1124\/pharmrev.122.000590_bib26","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/BF02245782","article-title":"Differentiation between the stimulus effects of (+)-lysergic acid diethylamide and lisuride using a three-choice, drug discrimination procedure","volume":"100","author":"Callahan","year":"1990","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/pharmrev.122.000590_bib27","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.1021\/acschemneuro.8b00692","article-title":"Chronic, intermittent microdoses of the psychedelic N,N-Dimethyltryptamine (DMT) produce positive effects on mood and anxiety in rodents","volume":"10","author":"Cameron","year":"2019","journal-title":"ACS Chem Neurosci"},{"key":"10.1124\/pharmrev.122.000590_bib28","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1021\/acschemneuro.8b00134","article-title":"Effects of N, N-dimethyltryptamine on rat behaviors relevant to anxiety and depression","volume":"9","author":"Cameron","year":"2018","journal-title":"ACS Chem Neurosci"},{"issue":"Suppl 2","key":"10.1124\/pharmrev.122.000590_bib29","doi-asserted-by":"crossref","first-page":"S101","DOI":"10.1590\/1516-4446-2013-1139","article-title":"Animal models of anxiety disorders and stress","volume":"35","author":"Campos","year":"2013","journal-title":"Br J Psychiatry"},{"key":"10.1124\/pharmrev.122.000590_bib30","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1126\/science.abl8615","article-title":"Structure-based discovery of nonhallucinogenic psychedelic analogs","volume":"375","author":"Cao","year":"2022","journal-title":"Science"},{"key":"10.1124\/pharmrev.122.000590_bib31","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1056\/NEJMoa2032994","article-title":"Trial of psilocybin versus escitalopram for depression","volume":"384","author":"Carhart-Harris","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1124\/pharmrev.122.000590_bib32","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.neuropharm.2018.03.010","article-title":"The entropic brain - revisited","volume":"142","author":"Carhart-Harris","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1124\/pharmrev.122.000590_bib33","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00213-017-4771-x","article-title":"Psilocybin with psychological support for treatment-resistant depression: six-month follow-up","volume":"235","author":"Carhart-Harris","year":"2018","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/pharmrev.122.000590_bib34","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1124\/pr.118.017160","article-title":"REBUS and the anarchic brain: toward a unified model of the brain action of psychedelics","volume":"71","author":"Carhart-Harris","year":"2019","journal-title":"Pharmacol Rev"},{"key":"10.1124\/pharmrev.122.000590_bib35","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1038\/npp.2017.84","article-title":"The therapeutic potential of psychedelic drugs: past, present, and future","volume":"42","author":"Carhart-Harris","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/pharmrev.122.000590_bib36","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1093\/schbul\/sbs117","article-title":"Functional connectivity measures after psilocybin inform a novel hypothesis of early psychosis","volume":"39","author":"Carhart-Harris","year":"2013","journal-title":"Schizophr Bull"},{"key":"10.1124\/pharmrev.122.000590_bib37","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3389\/fnhum.2014.00020","article-title":"The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs","volume":"8","author":"Carhart-Harris","year":"2014","journal-title":"Front Hum Neurosci"},{"key":"10.1124\/pharmrev.122.000590_bib38","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1177\/0269881117725915","article-title":"Serotonin and brain function: a tale of two receptors","volume":"31","author":"Carhart-Harris","year":"2017","journal-title":"J Psychopharmacol"},{"key":"10.1124\/pharmrev.122.000590_bib39","doi-asserted-by":"crossref","first-page":"13187","DOI":"10.1038\/s41598-017-13282-7","article-title":"Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms","volume":"7","author":"Carhart-Harris","year":"2017","journal-title":"Sci Rep"},{"key":"10.1124\/pharmrev.122.000590_bib40","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1126\/science.aan8868","article-title":"What constitutes the prefrontal cortex?","volume":"358","author":"Carl\u00e9n","year":"2017","journal-title":"Science"},{"key":"10.1124\/pharmrev.122.000590_bib41","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/s41398-020-0835-5","article-title":"Evidence-based umbrella review of 162 peripheral biomarkers for major mental disorders","volume":"10","author":"Carvalho","year":"2020","journal-title":"Transl Psychiatry"},{"key":"10.1124\/pharmrev.122.000590_bib42","doi-asserted-by":"crossref","first-page":"198ra105","DOI":"10.1126\/scitranslmed.3006294","article-title":"A theoretically based index of consciousness independent of sensory processing and behavior","volume":"5","author":"Casali","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1124\/pharmrev.122.000590_bib43","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s00221-013-3579-0","article-title":"Effects of psilocybin on hippocampal neurogenesis and extinction of trace fear conditioning","volume":"228","author":"Catlow","year":"2013","journal-title":"Exp Brain Res"},{"key":"10.1124\/pharmrev.122.000590_bib44","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1037\/0735-7044.117.4.774","article-title":"Effects of methamphetamine on duration discrimination","volume":"117","author":"Cevik","year":"2003","journal-title":"Behav Neurosci"},{"key":"10.1124\/pharmrev.122.000590_bib45","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1016\/j.jchromb.2011.07.003","article-title":"Determining the pharmacokinetics of psilocin in rat plasma using ultra-performance liquid chromatography coupled with a photodiode array detector after orally administering an extract of Gymnopilus spectabilis","volume":"879","author":"Chen","year":"2011","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1124\/pharmrev.122.000590_bib46","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0741-8329(02)00199-4","article-title":"GABA(A) receptor modulation of the rewarding and aversive effects of ethanol","volume":"26","author":"Chester","year":"2002","journal-title":"Alcohol"},{"key":"10.1124\/pharmrev.122.000590_bib47","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.neuropharm.2014.11.016","article-title":"Activation of 5-HT2a receptors in the basolateral amygdala promotes defeat-induced anxiety and the acquisition of conditioned defeat in Syrian hamsters","volume":"90","author":"Clinard","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1124\/pharmrev.122.000590_bib48","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s002130050317","article-title":"On the elevated plus-maze the anxiolytic-like effects of the 5-HT(1A) agonist, 8-OH-DPAT, but not the anxiogenic-like effects of the 5-HT(1A) partial agonist, buspirone, are blocked by the 5-HT1A antagonist, WAY 100635","volume":"132","author":"Collinson","year":"1997","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/pharmrev.122.000590_bib49","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/jcmm.13310","article-title":"The mechanism of acute fasting-induced antidepressant-like effects in mice","volume":"22","author":"Cui","year":"2018","journal-title":"J Cell Mol Med"},{"key":"10.1124\/pharmrev.122.000590_bib50","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1523\/JNEUROSCI.1659-20.2020","article-title":"Hallucinogens in mental health: preclinical and clinical studies on LSD, psilocybin, MDMA, and ketamine","volume":"41","author":"De Gregorio","year":"2021","journal-title":"J Neurosci"},{"key":"10.1124\/pharmrev.122.000590_bib51","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1038\/s41386-022-01301-9","article-title":"Repeated lysergic acid diethylamide (LSD) reverses stress-induced anxiety-like behavior, cortical synaptogenesis deficits and serotonergic neurotransmission decline","volume":"47","author":"De Gregorio","year":"2022","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/pharmrev.122.000590_bib52","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2020705118","article-title":"Lysergic acid diethylamide (LSD) promotes social behavior through mTORC1 in the excitatory neurotransmission","volume":"118","author":"De Gregorio","year":"2021","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pharmrev.122.000590_bib53","doi-asserted-by":"crossref","first-page":"108595","DOI":"10.1016\/j.jneumeth.2020.108595","article-title":"Automated quantification of head-twitch response in mice via ear tag reporter coupled with biphasic detection","volume":"334","author":"de la Fuente Revenga","year":"2020","journal-title":"J Neurosci Methods"},{"key":"10.1124\/pharmrev.122.000590_bib54","doi-asserted-by":"crossref","first-page":"109836","DOI":"10.1016\/j.celrep.2021.109836","article-title":"Prolonged epigenomic and synaptic plasticity alterations following single exposure to a psychedelic in mice","volume":"37","author":"de la Fuente Revenga","year":"2021","journal-title":"Cell Rep"},{"key":"10.1124\/pharmrev.122.000590_bib55","doi-asserted-by":"crossref","first-page":"106676","DOI":"10.1016\/j.vascn.2020.106676","article-title":"Marble-burying behavior test as a murine model of compulsive-like behavior","volume":"102","author":"Dixit","year":"2020","journal-title":"J Pharmacol Toxicol Methods"},{"key":"10.1124\/pharmrev.122.000590_bib56","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.pbb.2005.05.011","article-title":"Effects of clozapine and 2,5-dimethoxy-4-methylamphetamine [DOM] on 5-HT2A receptor expression in discrete brain areas","volume":"81","author":"Doat-Meyerhoefer","year":"2005","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/pharmrev.122.000590_bib57","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1038\/npp.2016.82","article-title":"LSD acutely impairs fear recognition and enhances emotional empathy and sociality","volume":"41","author":"Dolder","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/pharmrev.122.000590_bib58","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/brain\/awab406","article-title":"Models of psychedelic drug action: modulation of cortical-subcortical circuits","volume":"145","author":"Doss","year":"2022","journal-title":"Brain"},{"key":"10.1124\/pharmrev.122.000590_bib59","doi-asserted-by":"crossref","DOI":"10.1192\/j.eurpsy.2020.57","article-title":"Transdiagnostic and disease-specific abnormalities in the default-mode network hubs in psychiatric disorders: a meta-analysis of resting-state functional imaging studies","volume":"63","author":"Doucet","year":"2020","journal-title":"Eur Psychiatry"},{"key":"10.1124\/pharmrev.122.000590_bib60","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1016\/S0028-3908(00)00030-7","article-title":"Effects of strain and serotonergic agents on prepulse inhibition and habituation in mice","volume":"39","author":"Dulawa","year":"2000","journal-title":"Neuropharmacology"},{"key":"10.1124\/pharmrev.122.000590_bib61","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1248\/bpb.35.376","article-title":"Role of 5-hydroxytryptamine2C receptors in marble-burying behavior in mice","volume":"35","author":"Egashira","year":"2012","journal-title":"Biol Pharm Bull"},{"key":"10.1124\/pharmrev.122.000590_bib62","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1177\/02698811221104641","article-title":"Effects of acute lysergic acid diethylamide on intermittent ethanol and sucrose drinking and intracranial self-stimulation in C57BL\/6 mice","volume":"36","author":"Elsil\u00e4","year":"2022","journal-title":"J Psychopharm"},{"key":"10.1124\/pharmrev.122.000590_bib63","doi-asserted-by":"crossref","first-page":"602770","DOI":"10.3389\/fphar.2020.602770","article-title":"Acute lysergic acid diethylamide does not influence reward-driven decision making of C57BL\/6 mice in the iowa gambling task","volume":"11","author":"Elsil\u00e4","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1124\/pharmrev.122.000590_bib64","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1038\/jcbfm.2014.68","article-title":"Serotonin 2A receptor agonist binding in the human brain with [11C]Cimbi-36","volume":"34","author":"Ettrup","year":"2014","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1124\/pharmrev.122.000590_bib65","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/BF02247129","article-title":"Effects of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) on locomotor activity and rearing of mice and rats","volume":"102","author":"Evenden","year":"1990","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/pharmrev.122.000590_bib66","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.bcp.2007.07.018","article-title":"The behavioral pharmacology of hallucinogens","volume":"75","author":"Fantegrossi","year":"2008","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/pharmrev.122.000590_bib67","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/BF01990020","article-title":"Measurement of handwriting area to pressure ratios during psilocybin-induced hallucinations","volume":"1","author":"Fischer","year":"1969","journal-title":"Agents Actions"},{"key":"10.1124\/pharmrev.122.000590_bib68","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.neulet.2017.10.058","article-title":"Influence of intertrial interval on basal and drug-induced impulsive action in the 5-choice serial reaction time task: effects of d-amphetamine and (\u00b1)-2,5-dimethoxy-4-iodoamphetamine (DOI)","volume":"662","author":"Fitzpatrick","year":"2018","journal-title":"Neurosci Lett"},{"key":"10.1124\/pharmrev.122.000590_bib69","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00213-007-0891-z","article-title":"Opposing effects of 5-HT(2A) and 5-HT(2C) receptor antagonists in the rat and mouse on premature responding in the five-choice serial reaction time test","volume":"195","author":"Fletcher","year":"2007","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/pharmrev.122.000590_bib70","doi-asserted-by":"crossref","first-page":"9673","DOI":"10.1073\/pnas.0504136102","article-title":"The human brain is intrinsically organized into dynamic, anticorrelated functional networks","volume":"102","author":"Fox","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pharmrev.122.000590_bib71","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0376-8716(98)00154-9","article-title":"Behavioral profile of constituents in ayahuasca, an Amazonian psychoactive plant mixture","volume":"54","author":"Freedland","year":"1999","journal-title":"Drug Alcohol Depend"},{"key":"10.1124\/pharmrev.122.000590_bib72","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.jad.2015.09.005","article-title":"What are \u2018good\u2019 depression symptoms? Comparing the centrality of DSM and non-DSM symptoms of depression in a network analysis","volume":"189","author":"Fried","year":"2016","journal-title":"J Affect Disord"},{"key":"10.1124\/pharmrev.122.000590_bib73","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2174\/1874473708666150107121331","article-title":"Psilocybin-occasioned mystical experiences in the treatment of tobacco addiction","volume":"7","author":"Garcia-Romeu","year":"2014","journal-title":"Curr Drug Abuse Rev"},{"key":"10.1124\/pharmrev.122.000590_bib74","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1177\/0269881114555249","article-title":"LSD-assisted psychotherapy for anxiety associated with a life-threatening disease: a qualitative study of acute and sustained subjective effects","volume":"29","author":"Gasser","year":"2015","journal-title":"J Psychopharmacol"},{"key":"10.1124\/pharmrev.122.000590_bib75","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s002130100811","article-title":"Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review","volume":"156","author":"Geyer","year":"2001","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/pharmrev.122.000590_bib76","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/0006-3223(94)90019-1","article-title":"The effects of lisuride on mood and sleep during acute withdrawal in stimulant abusers: a preliminary report","volume":"35","author":"Gillin","year":"1994","journal-title":"Biol Psychiatry"},{"key":"10.1124\/pharmrev.122.000590_bib77","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S0022-3565(25)31571-5","article-title":"Effects of LSD on learning as measured by classical conditioning of the rabbit nictitating membrane response","volume":"208","author":"Gimpl","year":"1979","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pharmrev.122.000590_bib78","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1016\/0024-3205(84)90436-3","article-title":"Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents","volume":"35","author":"Glennon","year":"1984","journal-title":"Life Sci"},{"key":"10.1124\/pharmrev.122.000590_bib79","doi-asserted-by":"crossref","first-page":"112749","DOI":"10.1016\/j.psychres.2020.112749","article-title":"The experimental effects of psilocybin on symptoms of anxiety and depression: a meta-analysis","volume":"284","author":"Goldberg","year":"2020","journal-title":"Psychiatry Res"},{"key":"10.1124\/pharmrev.122.000590_bib80","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.neuron.2007.01.008","article-title":"Hallucinogens recruit specific cortical 5-HT(2A) receptor-mediated signaling pathways to affect behavior","volume":"53","author":"Gonz\u00e1lez-Maeso","year":"2007","journal-title":"Neuron"},{"key":"10.1124\/pharmrev.122.000590_bib81","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1177\/0269881116675513","article-title":"Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: a randomized double-blind trial","volume":"30","author":"Griffiths","year":"2016","journal-title":"J Psychopharmacol"},{"key":"10.1124\/pharmrev.122.000590_bib82","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1177\/0269881117731279","article-title":"Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial attitudes and behaviors","volume":"32","author":"Griffiths","year":"2018","journal-title":"J Psychopharmacol"},{"key":"10.1124\/pharmrev.122.000590_bib83","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.bbr.2010.05.039","article-title":"Characterization of behavioral and endocrine effects of LSD on zebrafish","volume":"214","author":"Grossman","year":"2010","journal-title":"Behav Brain Res"},{"key":"10.1124\/pharmrev.122.000590_bib84","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/s41583-019-0221-6","article-title":"The future of rodent models in depression research","volume":"20","author":"Gururajan","year":"2019","journal-title":"Nat Rev Neurosci"},{"key":"10.1124\/pharmrev.122.000590_bib85","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1093\/ijnp\/pyab040","article-title":"A complex impact of systemically administered 5-HT2A receptor ligands on conditioned fear","volume":"24","author":"Hags\u00e4ter","year":"2021","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1124\/pharmrev.122.000590_bib86","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1007\/s00213-018-4969-6","article-title":"Validation and optimisation of a touchscreen progressive ratio test of motivation in male rats","volume":"235","author":"Hailwood","year":"2018","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/pharmrev.122.000590_bib87","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.bbr.2014.07.016","article-title":"Recent advances in the neuropsychopharmacology of serotonergic hallucinogens","volume":"277","author":"Halberstadt","year":"2015","journal-title":"Behav Brain Res"},{"key":"10.1124\/pharmrev.122.000590_bib88","doi-asserted-by":"crossref","first-page":"8344","DOI":"10.1038\/s41598-020-65264-x","article-title":"Automated detection of the head-twitch response using wavelet scalograms and a deep convolutional neural network","volume":"10","author":"Halberstadt","year":"2020","journal-title":"Sci Rep"},{"key":"10.1124\/pharmrev.122.000590_bib89","doi-asserted-by":"crossref","first-page":"107933","DOI":"10.1016\/j.neuropharm.2019.107933","article-title":"Correlation between the potency of hallucinogens in the mouse head-twitch response assay and their behavioral and subjective effects in other species","volume":"167","author":"Halberstadt","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1124\/pharmrev.122.000590_bib90","series-title":"Encyclopedia of Behavioral Neuroscience","first-page":"12","article-title":"Hallucinogens","author":"Halberstadt","year":"2010"},{"key":"10.1124\/pharmrev.122.000590_bib91","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.neuropharm.2011.01.017","article-title":"Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens","volume":"61","author":"Halberstadt","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1124\/pharmrev.122.000590_bib92","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s00213-013-3006-z","article-title":"Characterization of the head-twitch response induced by hallucinogens in mice: detection of the behavior based on the dynamics of head movement","volume":"227","author":"Halberstadt","year":"2013","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/pharmrev.122.000590_bib93","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1017\/S1461145713000722","article-title":"Serotonergic hallucinogens as translational models relevant to schizophrenia","volume":"16","author":"Halberstadt","year":"2013","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1124\/pharmrev.122.000590_bib94","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/7854_2016_466","article-title":"Effect of hallucinogens on unconditioned behavior","volume":"36","author":"Halberstadt","year":"2018","journal-title":"Curr Top Behav Neurosci"},{"key":"10.1124\/pharmrev.122.000590_bib95","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1177\/0269881110388326","article-title":"Differential contributions of serotonin receptors to the behavioral effects of indoleamine hallucinogens in mice","volume":"25","author":"Halberstadt","year":"2011","journal-title":"J Psychopharmacol"},{"key":"10.1124\/pharmrev.122.000590_bib96","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.neuropharm.2016.03.038","article-title":"Effect of 5-HT2A and 5-HT2C receptors on temporal discrimination by mice","volume":"107","author":"Halberstadt","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1124\/pharmrev.122.000590_bib97","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1038\/npp.2009.29","article-title":"5-HT(2A) and 5-HT(2C) receptors exert opposing effects on locomotor activity in mice","volume":"34","author":"Halberstadt","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/pharmrev.122.000590_bib98","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/FBP.0b013e328334707a","article-title":"Comparison of the effects of 2,5-dimethoxy-4-iodoamphetamine and D-amphetamine on the ability of rats to discriminate the durations and intensities of light stimuli","volume":"21","author":"Hampson","year":"2010","journal-title":"Behav Pharmacol"},{"key":"10.1124\/pharmrev.122.000590_bib99","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1021\/cn300138m","article-title":"Animal models of serotonergic psychedelics","volume":"4","author":"Hanks","year":"2013","journal-title":"ACS Chem Neurosci"},{"key":"10.1124\/pharmrev.122.000590_bib100","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1021\/cn400216u","article-title":"Synthesis and structure-activity relationships of N-benzyl phenethylamines as 5-HT2A\/2C agonists","volume":"5","author":"Hansen","year":"2014","journal-title":"ACS Chem Neurosci"},{"key":"10.1124\/pharmrev.122.000590_bib101","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1177\/0269881116677852","article-title":"Set and setting, psychedelics and the placebo response: an extra-pharmacological perspective on psychopharmacology","volume":"30","author":"Hartogsohn","year":"2016","journal-title":"J Psychopharmacol"},{"key":"10.1124\/pharmrev.122.000590_bib102","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0022-3565(25)33055-7","article-title":"Effects of d-lysergic acid diethylamide, d-2-bromolysergic acid diethylamide, dl-2,5-dimethoxy-4-methylamphetamine and d-amphetamine on classical conditioning of the rabbit nictitating membrane response","volume":"221","author":"Harvey","year":"1982","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pharmrev.122.000590_bib103","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0089153","article-title":"Increased behavioral and neuronal responses to a hallucinogenic drug in PACAP heterozygous mutant mice","volume":"9","author":"Hazama","year":"2014","journal-title":"PLoS One"},{"key":"10.1124\/pharmrev.122.000590_bib104","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2022489118","article-title":"Harnessing psilocybin: antidepressant-like behavioral and synaptic actions of psilocybin are independent of 5-HT2R activation in mice","volume":"118","author":"Hesselgrave","year":"2021","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pharmrev.122.000590_bib105","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1021\/acschemneuro.9b00493","article-title":"Psychedelics, but not ketamine, produce persistent antidepressant-like effects in a rodent experimental system for the study of depression","volume":"11","author":"Hibicke","year":"2020","journal-title":"ACS Chem Neurosci"},{"key":"10.1124\/pharmrev.122.000590_bib106","series-title":"LSD My Problem Child, Reflections on Sacred Drugs, Mysticism, and Science","author":"Hofmann","year":"1983"},{"key":"10.1124\/pharmrev.122.000590_bib107","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1097\/FBP.0000000000000394","article-title":"Psilocin and ketamine microdosing: effects of subchronic intermittent microdoses in the elevated plus-maze in male Wistar rats","volume":"29","author":"Horsley","year":"2018","journal-title":"Behav Pharmacol"},{"key":"10.1124\/pharmrev.122.000590_bib108","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3143\/geriatrics.31.52","article-title":"Therapeutic effect of lisuride maleate on post-stroke depression","volume":"31","author":"Hougaku","year":"1994","journal-title":"Nihon Ronen Igakkai Zasshi"},{"key":"10.1124\/pharmrev.122.000590_bib109","doi-asserted-by":"crossref","first-page":"454","DOI":"10.4236\/jbbs.2012.24053","article-title":"5-HT 2A receptor activation normalizes exaggerated fear behavior in p-chlorophenylalanine (PCPA)-treated rats","volume":"2","author":"Hughes","year":"2012","journal-title":"J Behav Brain Sci"},{"key":"10.1124\/pharmrev.122.000590_bib110","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.pharmthera.2011.03.008","article-title":"Serotonin receptors and heart valve disease--it was meant 2B","volume":"132","author":"Hutcheson","year":"2011","journal-title":"Pharmacol Ther"},{"key":"10.1124\/pharmrev.122.000590_bib111","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1176\/appi.ajp.2010.09091379","article-title":"Research domain criteria (RDoC): toward a new classification framework for research on mental disorders","volume":"167","author":"Insel","year":"2010","journal-title":"Am J Psychiatry"},{"key":"10.1124\/pharmrev.122.000590_bib112","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0020124","article-title":"Why most published research findings are false","volume":"2","author":"Ioannidis","year":"2005","journal-title":"PLoS Med"},{"key":"10.1124\/pharmrev.122.000590_bib113","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.neuroscience.2016.03.021","article-title":"The neural basis of reversal learning: an updated perspective","volume":"345","author":"Izquierdo","year":"2017","journal-title":"Neuroscience"},{"key":"10.1124\/pharmrev.122.000590_bib114","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/jnc.15536","article-title":"Molecular targets of psychedelic-induced plasticity","volume":"162","author":"Jaster","year":"2022","journal-title":"J Neurochem"},{"key":"10.1124\/pharmrev.122.000590_bib115","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1007\/s00213-022-06092-x","article-title":"Effects of the 5-HT2A receptor antagonist volinanserin on head-twitch response and intracranial self-stimulation depression induced by different structural classes of psychedelics in rodents","volume":"239","author":"Jaster","year":"2022","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/pharmrev.122.000590_bib116","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1017\/neu.2019.15","article-title":"Psilocybin lacks antidepressant-like effect in the Flinders Sensitive Line rat","volume":"31","author":"Jefsen","year":"2019","journal-title":"Acta Neuropsychiatr"},{"key":"10.1124\/pharmrev.122.000590_bib117","doi-asserted-by":"crossref","first-page":"113979","DOI":"10.1016\/j.bcp.2020.113979","article-title":"The selective 5-HT2A receptor agonist 25CN-NBOH: Structure-activity relationship, in vivo pharmacology, and in vitro and ex vivo binding characteristics of [3H]25CN-NBOH","volume":"177","author":"Jensen","year":"2020","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/pharmrev.122.000590_bib118","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1124\/jpet.117.239905","article-title":"Detailed characterization of the in vitro pharmacological and pharmacokinetic properties of N-(2-hydroxybenzyl)-2,5-dimethoxy-4-cyanophenylethylamine (25CN-NBOH), a highly selective and brain-penetrant 5-HT2A receptor agonist","volume":"361","author":"Jensen","year":"2017","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pharmrev.122.000590_bib119","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.neuint.2019.02.007","article-title":"Abuse potential of 2-(4-iodo-2, 5-dimethoxyphenyl)N-(2-methoxybenzyl)ethanamine (25INBOMe); in vivo and ex vivo approaches","volume":"125","author":"Jeon","year":"2019","journal-title":"Neurochem Int"},{"key":"10.1124\/pharmrev.122.000590_bib120","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1177\/0269881108093587","article-title":"Human hallucinogen research: guidelines for safety","volume":"22","author":"Johnson","year":"2008","journal-title":"J Psychopharmacol"},{"key":"10.1124\/pharmrev.122.000590_bib121","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1177\/0269881114548296","article-title":"Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction","volume":"28","author":"Johnson","year":"2014","journal-title":"J Psychopharmacol"},{"key":"10.1124\/pharmrev.122.000590_bib122","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3109\/00952990.2016.1170135","article-title":"Long-term follow-up of psilocybin-facilitated smoking cessation","volume":"43","author":"Johnson","year":"2017","journal-title":"Am J Drug Alcohol Abuse"},{"key":"10.1124\/pharmrev.122.000590_bib123","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1007\/s13311-017-0542-y","article-title":"Potential therapeutic effects of psilocybin","volume":"14","author":"Johnson","year":"2017","journal-title":"Neurotherapeutics"},{"key":"10.1124\/pharmrev.122.000590_bib124","doi-asserted-by":"crossref","first-page":"19575","DOI":"10.1073\/pnas.0905884106","article-title":"Rapid modulation of spine morphology by the 5-HT2A serotonin receptor through kalirin-7 signaling","volume":"106","author":"Jones","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pharmrev.122.000590_bib125","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s00213-010-1887-7","article-title":"Role of serotonin 5-HT2A and 5-HT2C receptors on brain stimulation reward and the reward-facilitating effect of cocaine","volume":"213","author":"Katsidoni","year":"2011","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/pharmrev.122.000590_bib126","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0163-7258(97)00004-1","article-title":"The olfactory bulbectomized rat as a model of depression: an update","volume":"74","author":"Kelly","year":"1997","journal-title":"Pharmacol Ther"},{"key":"10.1124\/pharmrev.122.000590_bib127","doi-asserted-by":"crossref","first-page":"800072","DOI":"10.3389\/fpsyt.2021.800072","article-title":"Psychedelic therapy\u2019s transdiagnostic effects: a research domain criteria (RDoC) perspective","volume":"12","author":"Kelly","year":"2021","journal-title":"Front Psychiatry"},{"key":"10.1124\/pharmrev.122.000590_bib128","doi-asserted-by":"crossref","first-page":"3947","DOI":"10.1007\/s00213-015-4081-0","article-title":"The continuous performance test (rCPT) for mice: a novel operant touchscreen test of attentional function","volume":"232","author":"Kim","year":"2015","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/pharmrev.122.000590_bib129","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1016\/j.cell.2020.08.024","article-title":"Structure of a hallucinogen-activated Gq-coupled 5-HT2A serotonin receptor","volume":"182","author":"Kim","year":"2020","journal-title":"Cell"},{"key":"10.1124\/pharmrev.122.000590_bib130","doi-asserted-by":"crossref","DOI":"10.1111\/adb.13147","article-title":"The serotonin 2A receptor agonist TCB-2 attenuates heavy alcohol drinking and alcohol-induced midbrain inhibitory plasticity","volume":"27","author":"Kimmey","year":"2022","journal-title":"Addict Biol"},{"key":"10.1124\/pharmrev.122.000590_bib131","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1476-5381.1974.tb08611.x","article-title":"Reversal learning enhanced by lysergic acid diethylamide (LSD): concomitant rise in brain 5-hydroxytryptamine levels","volume":"52","author":"King","year":"1974","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pharmrev.122.000590_bib132","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0091-3057(89)90431-0","article-title":"Long-lasting alterations in behavior and brain neurochemistry following continuous low-level LSD administration","volume":"33","author":"King","year":"1989","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/pharmrev.122.000590_bib133","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ejphar.2003.09.008","article-title":"5-HT(1A) receptor full agonist, 8-OH-DPAT, exerts antidepressant-like effects in the forced swim test in ACTH-treated rats","volume":"481","author":"Kitamura","year":"2003","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/pharmrev.122.000590_bib134","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s00213-008-1314-5","article-title":"The effects of psychotomimetic and putative cognitive-enhancing drugs on the performance of a n-back working memory task in rats","volume":"202","author":"Ko","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/pharmrev.122.000590_bib135","doi-asserted-by":"crossref","first-page":"661233","DOI":"10.3389\/fpsyt.2021.661233","article-title":"Does psychedelic therapy have a transdiagnostic action and prophylactic potential?","volume":"12","author":"Ko\u010d\u00e1rov\u00e1","year":"2021","journal-title":"Front Psychiatry"},{"key":"10.1124\/pharmrev.122.000590_bib136","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.jpsychires.2012.11.018","article-title":"Prepulse inhibition in psychiatric disorders--apart from schizophrenia","volume":"47","author":"Kohl","year":"2013","journal-title":"J Psychiatr Res"},{"key":"10.1124\/pharmrev.122.000590_bib137","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.biopsych.2012.04.005","article-title":"Psilocybin biases facial recognition, goal-directed behavior, and mood state toward positive relative to negative emotions through different serotonergic subreceptors","volume":"72","author":"Kometer","year":"2012","journal-title":"Biol Psychiatry"},{"key":"10.1124\/pharmrev.122.000590_bib138","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0028-3908(99)00159-8","article-title":"Activation of 5-HT2A receptors impairs response control of rats in a five-choice serial reaction time task","volume":"39","author":"Koskinen","year":"2000","journal-title":"Neuropharmacology"},{"key":"10.1124\/pharmrev.122.000590_bib139","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0091-3057(00)00241-0","article-title":"The 5-HT(2) receptor activation enhances impulsive responding without increasing motor activity in rats","volume":"66","author":"Koskinen","year":"2000","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/pharmrev.122.000590_bib140","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0893-133X(97)00164-4","article-title":"Effects of hallucinogens on locomotor and investigatory activity and patterns: influence of 5-HT2A and 5-HT2C receptors","volume":"18","author":"Krebs-Thomson","year":"1998","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/pharmrev.122.000590_bib141","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s00213-006-0566-1","article-title":"The roles of 5-HT1A and 5-HT2 receptors in the effects of 5-MeO-DMT on locomotor activity and prepulse inhibition in rats","volume":"189","author":"Krebs-Thomson","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/pharmrev.122.000590_bib142","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/j.1476-5381.1979.tb07861.x","article-title":"Effects of drugs on behaviour of aggressive mice","volume":"65","author":"Krsiak","year":"1979","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pharmrev.122.000590_bib143","doi-asserted-by":"crossref","first-page":"49","DOI":"10.4103\/0253-7613.106435","article-title":"Evaluation of sesamol and buspirone in stress induced anxiety in mice","volume":"45","author":"Kumar","year":"2013","journal-title":"Indian J Pharmacol"},{"key":"10.1124\/pharmrev.122.000590_bib144","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s00213-009-1562-z","article-title":"The role of GABA(A) receptors in the acute and chronic effects of ethanol: a decade of progress","volume":"205","author":"Kumar","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/pharmrev.122.000590_bib145","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1124\/jpet.102.042184","article-title":"Serotonin 5-hydroxytryptamine 2A receptor-coupled phospholipase C and phospholipase A2 signaling pathways have different receptor reserves","volume":"304","author":"Kurrasch-Orbaugh","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pharmrev.122.000590_bib146","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.pnpbp.2012.01.003","article-title":"Effects of hallucinogenic agents mescaline and phencyclidine on zebrafish behavior and physiology","volume":"37","author":"Kyzar","year":"2012","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1124\/pharmrev.122.000590_bib147","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000026300","article-title":"Early LSD treatment in Denmark from 1960 to 1974: an analysis of possible and long-lasting changes in the adult personality following psychedelic treatment. A historical retrospective cohort study","volume":"100","author":"Larsen","year":"2021","journal-title":"Medicine (Baltimore)"},{"key":"10.1124\/pharmrev.122.000590_bib148","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1080\/02791072.2019.1683260","article-title":"Psychedelic microdosing: a subreddit analysis","volume":"52","author":"Lea","year":"2020","journal-title":"J Psychoactive Drugs"},{"key":"10.1124\/pharmrev.122.000590_bib149","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.bbrc.2022.01.113","article-title":"Gs signaling pathway distinguishes hallucinogenic and nonhallucinogenic 5-HT2AR agonists induced head twitch response in mice","volume":"598","author":"Liu","year":"2022","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/pharmrev.122.000590_bib150","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1073\/pnas.1200506109","article-title":"Rat brains also have a default mode network","volume":"109","author":"Lu","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pharmrev.122.000590_bib151","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1016\/j.celrep.2018.05.022","article-title":"Psychedelics promote structural and functional neural plasticity","volume":"23","author":"Ly","year":"2018","journal-title":"Cell Rep"},{"key":"10.1124\/pharmrev.122.000590_bib152","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1177\/0269881111420188","article-title":"Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness","volume":"25","author":"MacLean","year":"2011","journal-title":"J Psychopharmacol"},{"key":"10.1124\/pharmrev.122.000590_bib153","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s00213-008-1238-0","article-title":"Dopamine D4 receptor involvement in the discriminative stimulus effects in rats of LSD, but not the phenethylamine hallucinogen DOI","volume":"203","author":"Marona-Lewicka","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/pharmrev.122.000590_bib154","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.neuropharm.2011.02.006","article-title":"An animal model of schizophrenia based on chronic LSD administration: old idea, new results","volume":"61","author":"Marona-Lewicka","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1124\/pharmrev.122.000590_bib155","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/7854_2017_479","article-title":"The effects of hallucinogens on gene expression","volume":"36","author":"Martin","year":"2018","journal-title":"Curr Top Behav Neurosci"},{"key":"10.1124\/pharmrev.122.000590_bib156","first-page":"291","article-title":"Anxiolytic-like effects of DOI microinjections into the hippocampus (but not the amygdala nor the PAG) in the mice four plates test","volume":"188","author":"Masse","year":"2008","journal-title":"Behav Brain Res"},{"key":"10.1124\/pharmrev.122.000590_bib157","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1271\/bbb.90095","article-title":"Effects of Psilocybe argentipes on marble-burying behavior in mice","volume":"73","author":"Matsushima","year":"2009","journal-title":"Biosci Biotechnol Biochem"},{"key":"10.1124\/pharmrev.122.000590_bib158","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0091-3057(98)00115-4","article-title":"5-HT2A and 5-HT2C\/5-HT1B receptors are differentially involved in alcohol preference and consummatory behavior in cAA rats","volume":"62","author":"Maurel","year":"1999","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/pharmrev.122.000590_bib159","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0924-977X(00)00092-4","article-title":"Palatable fluids do not affect alcohol intake and its reduction by serotonergic compounds in alcohol-preferring cAA rats","volume":"10","author":"Maurel","year":"2000","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1124\/pharmrev.122.000590_bib160","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/s41573-022-00421-7","article-title":"The promises and perils of psychedelic pharmacology for psychiatry","volume":"21","author":"McClure-Begley","year":"2022","journal-title":"Nat Rev Drug Discov"},{"key":"10.1124\/pharmrev.122.000590_bib161","doi-asserted-by":"crossref","first-page":"5794","DOI":"10.1021\/jm060656o","article-title":"1-Aminomethylbenzocycloalkanes: conformationally restricted hallucinogenic phenethylamine analogues as functionally selective 5-HT2A receptor agonists","volume":"49","author":"McLean","year":"2006","journal-title":"J Med Chem"},{"key":"10.1124\/pharmrev.122.000590_bib162","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0091-3057(97)00391-2","article-title":"LSD produces conditioned place preference in male but not female fawn hooded rats","volume":"59","author":"Meehan","year":"1998","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/pharmrev.122.000590_bib163","doi-asserted-by":"crossref","first-page":"eabh2399","DOI":"10.1126\/sciadv.abh2399","article-title":"Psilocybin targets a common molecular mechanism for cognitive impairment and increased craving in alcoholism","volume":"7","author":"Meinhardt","year":"2021","journal-title":"Sci Adv"},{"key":"10.1124\/pharmrev.122.000590_bib164","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1038\/s41386-020-0694-z","article-title":"Psilocybin and LSD have no long-lasting effects in an animal model of alcohol relapse","volume":"45","author":"Meinhardt","year":"2020","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/pharmrev.122.000590_bib165","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.bbr.2007.06.026","article-title":"Stimulation of 5-HT1A, 5-HT1B, 5-HT2A\/2C, 5-HT3 and 5-HT4 receptors or 5-HT uptake inhibition: short- and long-term memory","volume":"184","author":"Meneses","year":"2007","journal-title":"Behav Brain Res"},{"key":"10.1124\/pharmrev.122.000590_bib166","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0166-4328(96)02266-8","article-title":"Role of 5-HT1B, 5-HT2A and 5-HT2C receptors in learning","volume":"87","author":"Meneses","year":"1997","journal-title":"Behav Brain Res"},{"key":"10.1124\/pharmrev.122.000590_bib167","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nrd3628","article-title":"Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy","volume":"11","author":"Millan","year":"2012","journal-title":"Nat Rev Drug Discov"},{"key":"10.1124\/pharmrev.122.000590_bib168","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.pbb.2014.04.003","article-title":"Effects of (+)-8-OH-DPAT on the duration of immobility during the forced swim test and hippocampal cell proliferation in ACTH-treated rats","volume":"122","author":"Miyake","year":"2014","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/pharmrev.122.000590_bib169","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1007\/s002130000542","article-title":"Effects of central 5-hydroxytryptamine depletion on sensitivity to delayed and probabilistic reinforcement","volume":"152","author":"Mobini","year":"2000","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/pharmrev.122.000590_bib170","first-page":"49","article-title":"The significance of the default mode network (DMN) in neurological and neuropsychiatric disorders: a review","volume":"89","author":"Mohan","year":"2016","journal-title":"Yale J Biol Med"},{"key":"10.1124\/pharmrev.122.000590_bib171","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.neuropharm.2018.09.004","article-title":"Reduced cortical serotonin 5-HT2A receptor binding and glutamate activity in high compulsive drinker rats","volume":"143","author":"Mora","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1124\/pharmrev.122.000590_bib172","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/s41398-020-01011-0","article-title":"N,N-dimethyltryptamine compound found in the hallucinogenic tea ayahuasca, regulates adult neurogenesis in vitro and in vivo","volume":"10","author":"Morales-Garcia","year":"2020","journal-title":"Transl Psychiatry"},{"key":"10.1124\/pharmrev.122.000590_bib173","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.4088\/JCP.v67n1110","article-title":"Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder","volume":"67","author":"Moreno","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"10.1124\/pharmrev.122.000590_bib174","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/BF00634451","article-title":"An evaluation of the elevated plus-maze test using the novel anxiolytic buspirone","volume":"99","author":"Moser","year":"1989","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/pharmrev.122.000590_bib175","doi-asserted-by":"crossref","first-page":"3263","DOI":"10.1002\/cmdc.202100395","article-title":"25CN-NBOH: a selective agonist for in\u2005vitro and in\u2005vivo investigations of the serotonin 2A receptor","volume":"16","author":"M\u00e4rcher R\u00f8rsted","year":"2021","journal-title":"ChemMedChem"},{"key":"10.1124\/pharmrev.122.000590_bib176","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/0976-0105.177703","article-title":"A simple practice guide for dose conversion between animals and human","volume":"7","author":"Nair","year":"2016","journal-title":"J Basic Clin Pharm"},{"key":"10.1124\/pharmrev.122.000590_bib177","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s00213-014-3699-7","article-title":"Activation of serotonin 5-HT2A receptors inhibits high compulsive drinking on schedule-induced polydipsia","volume":"232","author":"Navarro","year":"2015","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/pharmrev.122.000590_bib178","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1021\/cn400090q","article-title":"Perspectives on zebrafish models of hallucinogenic drugs and related psychotropic compounds","volume":"4","author":"Neelkantan","year":"2013","journal-title":"ACS Chem Neurosci"},{"key":"10.1124\/pharmrev.122.000590_bib179","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0166-4328(02)00311-X","article-title":"Anxiolytic-like effects of 5-HT2 ligands on three mouse models of anxiety","volume":"140","author":"Nic Dhonnchadha","year":"2003","journal-title":"Behav Brain Res"},{"key":"10.1124\/pharmrev.122.000590_bib180","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1124\/pr.115.011478","article-title":"Psychedelics","volume":"68","author":"Nichols","year":"2016","journal-title":"Pharmacol Rev"},{"key":"10.1124\/pharmrev.122.000590_bib181","first-page":"1","article-title":"Chemistry and structure\u2013activity relationships of psychedelics","volume":"36","author":"Nichols","year":"2018","journal-title":"Curr Top Behav Neurosci"},{"key":"10.1124\/pharmrev.122.000590_bib182","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1055\/s-1999-3490","article-title":"Improvements to the synthesis of psilocybin and a facile method for preparing the O-acetyl prodrug of psilocin","volume":"1999","author":"Nichols","year":"1999","journal-title":"Synthesis"},{"key":"10.1124\/pharmrev.122.000590_bib183","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ejphar.2006.07.015","article-title":"A combined marble burying-locomotor activity test in mice: a practical screening test with sensitivity to different classes of anxiolytics and antidepressants","volume":"547","author":"Nicolas","year":"2006","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/pharmrev.122.000590_bib184","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0091-3057(91)90590-X","article-title":"Evaluation of marble-burying behavior as a model of anxiety","volume":"38","author":"Njung\u2019e","year":"1991","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/pharmrev.122.000590_bib185","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1001\/jamapsychiatry.2020.2171","article-title":"The current status of psychedelics in psychiatry","volume":"78","author":"Nutt","year":"2021","journal-title":"JAMA Psychiatry"},{"key":"10.1124\/pharmrev.122.000590_bib186","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1016\/S0140-6736(10)61462-6","article-title":"Drug harms in the UK: a multicriteria decision analysis","volume":"376","author":"Nutt","year":"2010","journal-title":"Lancet"},{"key":"10.1124\/pharmrev.122.000590_bib187","doi-asserted-by":"crossref","first-page":"107838","DOI":"10.1016\/j.neuropharm.2019.107838","article-title":"The 5-hydroxytryptamine 2A receptor agonists DOI and 25CN-NBOH decrease marble burying and reverse 8-OH-DPAT-induced deficit in spontaneous alternation","volume":"183","author":"Odland","year":"2021","journal-title":"Neuropharmacology"},{"key":"10.1124\/pharmrev.122.000590_bib188","doi-asserted-by":"crossref","first-page":"113093","DOI":"10.1016\/j.bbr.2020.113093","article-title":"Investigating the role of 5-HT2A and 5-HT2C receptor activation in the effects of psilocybin, DOI, and citalopram on marble burying in mice","volume":"401","author":"Odland","year":"2021","journal-title":"Behav Brain Res"},{"key":"10.1124\/pharmrev.122.000590_bib189","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/FBP.0000000000000626","article-title":"The selective 5-HT2A receptor agonist 25CN-NBOH does not affect reversal learning in mice","volume":"32","author":"Odland","year":"2021","journal-title":"Behav Pharmacol"},{"key":"10.1124\/pharmrev.122.000590_bib190","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/0278-5846(92)90104-M","article-title":"Rodent models of aggressive behavior and serotonergic drugs","volume":"16","author":"Olivier","year":"1992","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1124\/pharmrev.122.000590_bib191","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1021\/acsptsci.0c00192","article-title":"The subjective effects of psychedelics may not be necessary for their enduring therapeutic effects","volume":"4","author":"Olson","year":"2020","journal-title":"ACS Pharmacol Transl Sci"},{"key":"10.1124\/pharmrev.122.000590_bib192","doi-asserted-by":"crossref","first-page":"3567","DOI":"10.1007\/s00213-019-05328-7","article-title":"Effects of the synthetic psychedelic 2,5-dimethoxy-4-iodoamphetamine (DOI) on ethanol consumption and place conditioning in male mice","volume":"236","author":"Oppong-Damoah","year":"2019","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/pharmrev.122.000590_bib193","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0893-133X(01)00282-2","article-title":"Effect of LSD on prepulse inhibition and spontaneous behavior in the rat. A pharmacological analysis and comparison between two rat strains","volume":"25","author":"Ouagazzal","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/pharmrev.122.000590_bib194","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s00213-007-0926-5","article-title":"Mescaline effects on rat behavior and its time profile in serum and brain tissue after a single subcutaneous dose","volume":"196","author":"P\u00e1len\u00edcek","year":"2008","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/pharmrev.122.000590_bib195","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1037\/0735-7044.110.3.503","article-title":"LSD produces place preference and flavor avoidance but does not produce flavor aversion in rats","volume":"110","author":"Parker","year":"1996","journal-title":"Behav Neurosci"},{"key":"10.1124\/pharmrev.122.000590_bib196","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1080\/1355621021000005937","article-title":"The pharmacology of psilocybin","volume":"7","author":"Passie","year":"2002","journal-title":"Addict Biol"},{"key":"10.1124\/pharmrev.122.000590_bib197","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/978-3-319-16522-6_10","article-title":"Social cognition","volume":"228","author":"Patin","year":"2015","journal-title":"Handb Exp Pharmacol"},{"key":"10.1124\/pharmrev.122.000590_bib198","article-title":"The ARRIVE guidelines 2.0: updated guidelines for reporting animal research","volume":"18","author":"Percie du Sert","year":"2020","journal-title":"PLoS Biol"},{"key":"10.1124\/pharmrev.122.000590_bib199","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1001\/jamapsychiatry.2021.3972","article-title":"The rapid rise in investment in psychedelics-cart before the horse","volume":"79","author":"Phelps","year":"2022","journal-title":"JAMA Psychiatry"},{"key":"10.1124\/pharmrev.122.000590_bib200","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.beproc.2015.05.004","article-title":"Behavioural and neurotoxic effects of ayahuasca infusion (Banisteriopsis caapi and Psychotria viridis) in female Wistar rat","volume":"118","author":"Pic-Taylor","year":"2015","journal-title":"Behav Processes"},{"key":"10.1124\/pharmrev.122.000590_bib201","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.3762\/bjoc.8.194","article-title":"trans-2-(2,5-Dimethoxy-4-iodophenyl)cyclopropylamine and trans-2-(2,5-dimethoxy-4-bromophenyl)cyclopropylamine as potent agonists for the 5-HT(2) receptor family","volume":"8","author":"Pigott","year":"2012","journal-title":"Beilstein J Org Chem"},{"key":"10.1124\/pharmrev.122.000590_bib202","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1017\/S0033291719002393","article-title":"LSD acutely impairs working memory, executive functions, and cognitive flexibility, but not risk-based decision-making","volume":"50","author":"Pokorny","year":"2020","journal-title":"Psychol Med"},{"key":"10.1124\/pharmrev.122.000590_bib203","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0006-2952(01)00677-3","article-title":"Agonist-induced functional desensitization of recombinant human 5-HT2 receptors expressed in CHO-K1 cells","volume":"62","author":"Porter","year":"2001","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/pharmrev.122.000590_bib204","doi-asserted-by":"crossref","first-page":"3603","DOI":"10.1523\/JNEUROSCI.1939-17.2018","article-title":"Role of the 5-HT2A receptor in self- and other-initiated social interaction in lysergic acid diethylamide-induced states: a pharmacological fMRI study","volume":"38","author":"Preller","year":"2018","journal-title":"J Neurosci"},{"key":"10.1124\/pharmrev.122.000590_bib205","doi-asserted-by":"crossref","first-page":"180","DOI":"10.3389\/fnbeh.2014.00180","article-title":"The effect of psilocin on memory acquisition, retrieval, and consolidation in the rat","volume":"8","author":"Rambousek","year":"2014","journal-title":"Front Behav Neurosci"},{"key":"10.1124\/pharmrev.122.000590_bib206","doi-asserted-by":"crossref","first-page":"835","DOI":"10.3390\/ijms22020835","article-title":"A single dose of psilocybin increases synaptic density and decreases 5-HT(2A) receptor density in the pig brain","volume":"22","author":"Raval","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1124\/pharmrev.122.000590_bib207","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/e580a864-cf13-40c2-9bd9-b9687a6f0fe4","article-title":"Psychedelics and the human receptorome","volume":"5","author":"Ray","year":"2010","journal-title":"PLoS One"},{"key":"10.1124\/pharmrev.122.000590_bib208","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s00213-005-0068-6","article-title":"The 5-HT1A receptor and the stimulus effects of LSD in the rat","volume":"182","author":"Reissig","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/pharmrev.122.000590_bib209","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.neuropharm.2015.08.034","article-title":"Receptor interaction profiles of novel N-2-methoxybenzyl (NBOMe) derivatives of 2,5-dimethoxy-substituted phenethylamines (2C drugs)","volume":"99","author":"Rickli","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1124\/pharmrev.122.000590_bib210","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.euroneuro.2016.05.001","article-title":"Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens","volume":"26","author":"Rickli","year":"2016","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1124\/pharmrev.122.000590_bib211","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3389\/fnhum.2014.00204","article-title":"The effects of psilocybin and MDMA on between-network resting state functional connectivity in healthy volunteers","volume":"8","author":"Roseman","year":"2014","journal-title":"Front Hum Neurosci"},{"key":"10.1124\/pharmrev.122.000590_bib212","doi-asserted-by":"crossref","first-page":"974","DOI":"10.3389\/fphar.2017.00974","article-title":"Quality of acute psychedelic experience predicts therapeutic efficacy of psilocybin for treatment-resistant depression","volume":"8","author":"Roseman","year":"2018","journal-title":"Front Pharmacol"},{"key":"10.1124\/pharmrev.122.000590_bib213","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00213-007-0710-6","article-title":"Antidepressant-like effects of the novel, selective, 5-HT2C receptor agonist WAY-163909 in rodents","volume":"192","author":"Rosenzweig-Lipson","year":"2007","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/pharmrev.122.000590_bib214","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.neuropharm.2011.01.012","article-title":"Irving Page Lecture: 5-HT(2A) serotonin receptor biology: interacting proteins, kinases and paradoxical regulation","volume":"61","author":"Roth","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1124\/pharmrev.122.000590_bib215","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1161\/01.CIR.102.23.2836","article-title":"Evidence for possible involvement of 5-HT(2B) receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications","volume":"102","author":"Rothman","year":"2000","journal-title":"Circulation"},{"key":"10.1124\/pharmrev.122.000590_bib216","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1177\/026988119801200210","article-title":"5-HT1A receptor agonist (8-OH-DPAT) and 5-HT2 receptor agonist (DOI) disrupt the non-cognitive performance of rats in a working memory task","volume":"12","author":"Ruotsalainen","year":"1998","journal-title":"J Psychopharmacol"},{"key":"10.1124\/pharmrev.122.000590_bib217","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1254\/jjp.89.89","article-title":"Modulation by 5-hT2A receptors of aggressive behavior in isolated mice","volume":"89","author":"Sakaue","year":"2002","journal-title":"Jpn J Pharmacol"},{"key":"10.1124\/pharmrev.122.000590_bib218","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1037\/pha0000253","article-title":"Effects of acute and repeated treatment with serotonin 5-HT2A receptor agonist hallucinogens on intracranial self-stimulation in rats","volume":"27","author":"Sakloth","year":"2019","journal-title":"Exp Clin Psychopharmacol"},{"key":"10.1124\/pharmrev.122.000590_bib219","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/BF02246950","article-title":"The role of serotonergic mechanisms in inhibition of isolation-induced aggression in male mice","volume":"110","author":"S\u00e1nchez","year":"1993","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/pharmrev.122.000590_bib220","doi-asserted-by":"crossref","first-page":"4555","DOI":"10.1016\/j.bmcl.2005.06.104","article-title":"SAR of psilocybin analogs: discovery of a selective 5-HT 2C agonist","volume":"15","author":"Sard","year":"2005","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1124\/pharmrev.122.000590_bib221","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/BF00428319","article-title":"Severe aggression in rats induced by mescaline but not other hallucinogens","volume":"66","author":"Sbordone","year":"1979","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/pharmrev.122.000590_bib222","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0002-9459(24)07817-3","article-title":"Ergot and its alkaloids","volume":"70","author":"Schiff","year":"2006","journal-title":"Am J Pharm Educ"},{"key":"10.1124\/pharmrev.122.000590_bib223","doi-asserted-by":"crossref","first-page":"20150081","DOI":"10.1098\/rstb.2015.0081","article-title":"Towards a second-person neuropsychiatry","volume":"371","author":"Schilbach","year":"2016","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"10.1124\/pharmrev.122.000590_bib224","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1073\/pnas.0708862105","article-title":"Agonist-directed signaling of the serotonin 2A receptor depends on beta-arrestin-2 interactions in vivo","volume":"105","author":"Schmid","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pharmrev.122.000590_bib225","doi-asserted-by":"crossref","first-page":"niz003","DOI":"10.1093\/nc\/niz003","article-title":"Psychedelics as a treatment for disorders of consciousness","volume":"2019","author":"Scott","year":"2019","journal-title":"Neurosci Conscious"},{"key":"10.1124\/pharmrev.122.000590_bib226","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1016\/j.neuron.2021.06.008","article-title":"Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex in vivo","volume":"109","author":"Shao","year":"2021","journal-title":"Neuron"},{"key":"10.1124\/pharmrev.122.000590_bib227","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/0091-3057(88)90476-5","article-title":"Effects of LSD-25 on classical trace conditioning","volume":"30","author":"Siegel","year":"1988","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/pharmrev.122.000590_bib228","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/0028-3908(94)90074-4","article-title":"Multiple serotonin receptor subtypes modulate prepulse inhibition of the startle response in rats","volume":"33","author":"Sipes","year":"1994","journal-title":"Neuropharmacology"},{"key":"10.1124\/pharmrev.122.000590_bib229","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1097\/00008877-199512000-00010","article-title":"DOI disruption of prepulse inhibition of startle in the rat is mediated by 5-HT(2A) and not by 5-HT(2C) receptors","volume":"6","author":"Sipes","year":"1995","journal-title":"Behav Pharmacol"},{"key":"10.1124\/pharmrev.122.000590_bib230","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.neuroimage.2019.04.009","article-title":"Psilocybin-assisted mindfulness training modulates self-consciousness and brain default mode network connectivity with lasting effects","volume":"196","author":"Smigielski","year":"2019","journal-title":"Neuroimage"},{"key":"10.1124\/pharmrev.122.000590_bib231","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.neubiorev.2005.03.010","article-title":"The olfactory bulbectomised rat as a model of depression","volume":"29","author":"Song","year":"2005","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1124\/pharmrev.122.000590_bib232","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/oxfordjournals.schbul.a033326","article-title":"Using an animal model of deficient sensorimotor gating to study the pathophysiology and new treatments of schizophrenia","volume":"24","author":"Swerdlow","year":"1998","journal-title":"Schizophr Bull"},{"key":"10.1124\/pharmrev.122.000590_bib233","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/s002130100799","article-title":"Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challenges","volume":"156","author":"Swerdlow","year":"2001","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/pharmrev.122.000590_bib234","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00213-008-1072-4","article-title":"Realistic expectations of prepulse inhibition in translational models for schizophrenia research","volume":"199","author":"Swerdlow","year":"2008","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/pharmrev.122.000590_bib235","doi-asserted-by":"crossref","first-page":"586682","DOI":"10.3389\/fpsyt.2021.586682","article-title":"Development and evaluation of a therapist training program for psilocybin therapy for treatment-resistant depression in clinical research","volume":"12","author":"Tai","year":"2021","journal-title":"Front Psychiatry"},{"key":"10.1124\/pharmrev.122.000590_bib236","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00213-009-1466-y","article-title":"Marble burying reflects a repetitive and perseverative behavior more than novelty-induced anxiety","volume":"204","author":"Thomas","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/pharmrev.122.000590_bib237","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1007\/s11064-020-03153-5","article-title":"The chronic treatment with 5-HT2A receptor agonists affects the behavior and the BDNF system in mice","volume":"45","author":"Tsybko","year":"2020","journal-title":"Neurochem Res"},{"key":"10.1124\/pharmrev.122.000590_bib238","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/sj.npp.1300005","article-title":"Effects of the 5-HT2A agonist psilocybin on mismatch negativity generation and AX-continuous performance task: implications for the neuropharmacology of cognitive deficits in schizophrenia","volume":"28","author":"Umbricht","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/pharmrev.122.000590_bib239","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/jpet.106.104463","article-title":"Functional selectivity and classical concepts of quantitative pharmacology","volume":"320","author":"Urban","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pharmrev.122.000590_bib240","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1111\/ejn.13572","article-title":"A single administration of the hallucinogen, 4-acetoxy-dimethyltryptamine, prevents the shift to a drug-dependent state and the expression of withdrawal aversions in rodents","volume":"45","author":"Vargas-P\u00e9rez","year":"2017","journal-title":"Eur J Neurosci"},{"key":"10.1124\/pharmrev.122.000590_bib241","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1126\/science.1168501","article-title":"Ventral tegmental area BDNF induces an opiate-dependent-like reward state in naive rats","volume":"324","author":"Vargas-Perez","year":"2009","journal-title":"Science"},{"key":"10.1124\/pharmrev.122.000590_bib242","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1038\/sj.npp.1301324","article-title":"The effects of the preferential 5-HT2A agonist psilocybin on prepulse inhibition of startle in healthy human volunteers depend on interstimulus interval","volume":"32","author":"Vollenweider","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/pharmrev.122.000590_bib243","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/s41583-020-0367-2","article-title":"Psychedelic drugs: neurobiology and potential for treatment of psychiatric disorders","volume":"21","author":"Vollenweider","year":"2020","journal-title":"Nat Rev Neurosci"},{"key":"10.1124\/pharmrev.122.000590_bib244","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.1097\/00001756-199812010-00024","article-title":"Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action","volume":"9","author":"Vollenweider","year":"1998","journal-title":"Neuroreport"},{"key":"10.1124\/pharmrev.122.000590_bib245","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0091-3057(78)90016-3","article-title":"Effects of N,N-dimethyltryptamine (DMT) and 5-methoxy-N,N-dimethyltryptamine (5-MeODMT) on shock elicited fighting in rats","volume":"9","author":"Walters","year":"1978","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/pharmrev.122.000590_bib246","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ejphar.2007.08.045","article-title":"The antidepressant effects of curcumin in the forced swimming test involve 5-HT1 and 5-HT2 receptors","volume":"578","author":"Wang","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/pharmrev.122.000590_bib247","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1177\/0022167817709585","article-title":"Patients\u2019 accounts of increased \u201cconnectedness\u201d and \u201cacceptance\u201d after psilocybin for treatment-resistant depression","volume":"57","author":"Watts","year":"2017","journal-title":"J Humanist Psychol"},{"key":"10.1124\/pharmrev.122.000590_bib248","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00427414","article-title":"The validity of animal models of depression","volume":"83","author":"Willner","year":"1984","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/pharmrev.122.000590_bib249","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s00213-008-1356-8","article-title":"Hallucinogens as discriminative stimuli in animals: LSD, phenethylamines, and tryptamines","volume":"203","author":"Winter","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/pharmrev.122.000590_bib250","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0091-3057(99)00178-1","article-title":"The paradox of 5-methoxy-N,N-dimethyltryptamine: an indoleamine hallucinogen that induces stimulus control via 5-HT1A receptors","volume":"65","author":"Winter","year":"2000","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/pharmrev.122.000590_bib251","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.pbb.2005.05.014","article-title":"The stimulus properties of LSD in C57BL\/6 mice","volume":"81","author":"Winter","year":"2005","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/pharmrev.122.000590_bib252","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.pbb.2007.06.003","article-title":"Psilocybin-induced stimulus control in the rat","volume":"87","author":"Winter","year":"2007","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/pharmrev.122.000590_bib253","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.pbb.2012.03.011","article-title":"DOI-induced deficits in prepulse inhibition in Wistar rats are reversed by mGlu2\/3 receptor stimulation","volume":"102","author":"Wischhof","year":"2012","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/pharmrev.122.000590_bib254","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s00213-011-2441-y","article-title":"Pre-treatment with the mGlu2\/3 receptor agonist LY379268 attenuates DOI-induced impulsive responding and regional c-Fos protein expression","volume":"219","author":"Wischhof","year":"2012","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/pharmrev.122.000590_bib255","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1177\/0269881106065859","article-title":"Effects of psilocybin on time perception and temporal control of behaviour in humans","volume":"21","author":"Wittmann","year":"2007","journal-title":"J Psychopharmacol"},{"key":"10.1124\/pharmrev.122.000590_bib256","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.neuropharm.2016.02.020","article-title":"Orbitofrontal cortex 5-HT2A receptor mediates chronic stress-induced depressive-like behaviors and alterations of spine density and Kalirin7","volume":"109","author":"Xu","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1124\/pharmrev.122.000590_bib257","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/0091-3057(91)90559-K","article-title":"Spontaneous alternation behavior: an animal model for obsessive-compulsive disorder?","volume":"40","author":"Yadin","year":"1991","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/pharmrev.122.000590_bib258","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1007\/s00213-018-5119-x","article-title":"The effects of microdose LSD on time perception: a randomised, double-blind, placebo-controlled trial","volume":"236","author":"Yanakieva","year":"2019","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/pharmrev.122.000590_bib259","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.neuropharm.2012.06.007","article-title":"Stimulation of serotonin 2A receptors facilitates consolidation and extinction of fear memory in C57BL\/6J mice","volume":"64","author":"Zhang","year":"2013","journal-title":"Neuropharmacology"}],"container-title":["Pharmacological Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031699724007439?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031699724007439?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/pharmrev.122.000590","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T09:31:32Z","timestamp":1739871092000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031699724007439"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":259,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S0031699724007439"],"URL":"https:\/\/doi.org\/10.1124\/pharmrev.122.000590","relation":{},"ISSN":["0031-6997"],"issn-type":[{"value":"0031-6997","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Animal Behavior in Psychedelic Research","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/pharmrev.122.000590","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}